Publicação: Thiazole, triazole, thio- and semicarbazone derivatives - Promising moieties for drug development for the treatment of tuberculosis
dc.contributor.author | Scarim, Cauê Benito [UNESP] | |
dc.contributor.author | Pavan, Fernando Rogério [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
dc.date.accessioned | 2023-07-29T14:03:08Z | |
dc.date.available | 2023-07-29T14:03:08Z | |
dc.date.issued | 2021-07-01 | |
dc.description.abstract | Thiazole, triazole, thio and semicarbazones are privileged motifs that act as pharmacophores in bioactive compounds for various diseases, such as Tuberculosis (TB). Tuberculosis (TB) is an infectious disease caused mainly by Mycobacterium tuberculosis and was responsible for 4,000 deaths a day in 2019 worldwide. The resistance and the gap of new drugs is the main cause of the slow drop in TB infections. In this review article, we analyse recent contributions of thiazole, triazole, thio and semicarbazone scaffolds to anti-TB drugs. Beyond these recent trends, we demonstrate the potential of the thiazole, triazole, thio and semicarbazone approach in the medicinal chemistry field of anti-M. tuberculosis drug discovery. | en |
dc.description.affiliation | Sao Paulo State University (UNESP) School of Pharmaceutical Sciences, SP | |
dc.description.affiliationUnesp | Sao Paulo State University (UNESP) School of Pharmaceutical Sciences, SP | |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorshipId | FAPESP: 2016/10847- 9 | |
dc.description.sponsorshipId | FAPESP: 2020/13497-4 | |
dc.description.sponsorshipId | CNPq: 303603/2018-6 | |
dc.description.sponsorshipId | CNPq: 404181/2019-8 | |
dc.description.sponsorshipId | CNPq: 429139/2018-7 | |
dc.identifier | http://dx.doi.org/10.1016/j.ejmcr.2021.100002 | |
dc.identifier.citation | European Journal of Medicinal Chemistry Reports, v. 1. | |
dc.identifier.doi | 10.1016/j.ejmcr.2021.100002 | |
dc.identifier.issn | 2772-4174 | |
dc.identifier.scopus | 2-s2.0-85130266787 | |
dc.identifier.uri | http://hdl.handle.net/11449/249126 | |
dc.language.iso | eng | |
dc.relation.ispartof | European Journal of Medicinal Chemistry Reports | |
dc.source | Scopus | |
dc.subject | Mycobacterium tuberculosis | |
dc.subject | New compounds | |
dc.subject | Thiazole | |
dc.subject | Thio and semicarbazones | |
dc.subject | Triazole | |
dc.title | Thiazole, triazole, thio- and semicarbazone derivatives - Promising moieties for drug development for the treatment of tuberculosis | en |
dc.type | Resenha | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | 5004bcab-94af-4939-b980-091ae9d0a19e | |
relation.isDepartmentOfPublication.latestForDiscovery | 5004bcab-94af-4939-b980-091ae9d0a19e | |
unesp.department | Ciências Biológicas - FCF | pt |